癌症化疗和药理学 SCIE

期刊简介估计审稿时候： 约2.5月

Addressing a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels, Cancer Chemotherapy and Pharmacology is an eminent journal in the field. The primary focus in this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials. It is essential reading for pharmacologists and oncologists giving results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy.

《癌症化疗和药理学》是该范畴的闻名期刊，它触及尝试和临床层面的普遍药理学和肿瘤学题目。这类疾速出书前言的首要重点是新型抗癌药物、其尝试挑选、临床前毒理学和药理学、单一和结合用药体例和临床 I、II 和 III 期实验。它是药理学家和肿瘤学家的必读读物，记实了以下范畴的研讨功效：临床毒理学、药代能源学、药效学、药物彼此感化和癌症医治战略中化疗的顺应症。

《Cancer Chemotherapy And Pharmacology》(癌症化疗和药理学)编辑部通信体例为SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013。若是您须要辅佐投稿或润稿办事，您可以或许征询咱们的客服教员。咱们专一于期刊征询办事十年，熟习颁发政策，可为您供给一对一投稿指点，防止您在投稿时频仍碰鼻，节流您的可贵时候，有用晋升颁发机率，确保SCI检索（检索不了全额退款）。咱们视诺言为生命，多方面确保文章宁静失密，在任何环境下都不会泄漏您的小我信息或稿件内容。